Richard F. Little

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 952 citations · Full text

Medicine, Immunology, Oncology +10

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 738 citations · Full text

Medicine, Immunology, Oncology +16

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski et al. · Cancer Cell · 2017 · 499 citations · Full text

Medicine, Oncology, Pharmacology +14

Low-Intensity Therapy in Adults with Burkitt's Lymphoma

Kieron Dunleavy, Stefania Pittaluga, Margaret Shovlin et al. · New England Journal of Medicine · 2013 · 360 citations · Full text

Medicine, Oncology, Pharmacology +9

Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

Richard F. Little, Stefania Pittaluga, Nicole Grant et al. · Blood · 2003 · 355 citations

Life Sciences, Immunology, Oncology +12